Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "662b9e02f7fe09029cbf507e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CAPECITIME 500 ", "description": "CAPECITIME 500 \nCapecitabine lp (500mg)\n CAPECITIME 500, a potent medication containing 500mg of Capecitabine lp. This formulation is crucial in treating various types of cancer, including breast, colorectal, and gastric cancers. CAPECITIME 500 works by inhibiting the growth of cancer cells, preventing their spread, and improving overall survival rates. With its targeted approach and minimal side effects, CAPECITIME 500 offers hope and quality of life to patients battling cancer. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 1298.0, "discountamount": 390.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "hope", "life", "500mg", "spread", "growth", "quality", "patients", "colorectal", "CAPECITIME", "formulation", "Capecitabine", "cancer cells", "various types", "gastric cancers", "targeted approach", "potent medication", "minimal side effects", "overall survival rates" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 769, "imageuri": "https://productimages.withfloats.com/actual/662b9e05481840e7a7fd9a57.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b9e05481840e7a7fd9a57.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:28:50.711Z", "updatedon": "2024-06-07T12:32:26.577Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/capecitime-500-/769", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Capecitabine lp (500mg)", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEPRIDE 150", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 1050.0, "discountamount": 315.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2025-05-16T12:03:30.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintepride-150/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Nintedanib 150mg", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6822f6b2ab5024c71f211f50", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ZOLMIGRAN", "description": "ZOLMIGRAN is a powerful intravenous medication containing Zoledronic Acid 5mg, designed to treat and prevent bone-related complications in various conditions such as osteoporosis, Paget’s disease of bone, and cancers that affect bones. It belongs to a class of drugs known as bisphosphonates, which help in strengthening bones, reducing bone loss, and preventing fractures. ZOLMIGRAN is often recommended when oral treatments are ineffective or not well-tolerated.\n\nKey Ingredients\nZoledronic Acid (5mg): The active pharmaceutical ingredient responsible for inhibiting bone resorption and maintaining bone density.\n\nKey Benefits\nHelps in the treatment of osteoporosis in postmenopausal women and men at high risk of fractures.\n\nEffective in treating Paget's disease of bone, promoting normal bone formation.\n\nReduces the risk of bone fractures in patients with cancer that has spread to bones.\n\nPrevents skeletal-related events (SREs) like bone pain, fractures, and spinal cord compression in metastatic bone diseases.\n\nOffers a once-yearly infusion for osteoporosis, improving patient compliance.\n\nHow Does It Work?\nZOLMIGRAN works by binding strongly to the bone surface, specifically at sites of active resorption. Zoledronic Acid inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue. By reducing osteoclast activity, it slows down the process of bone resorption, leading to increased bone mass and strength. This action helps in stabilizing bone structure, reducing the likelihood of fractures and other bone complications.\n\nDirections for Use\nZOLMIGRAN is administered as an intravenous infusion by a healthcare professional.\n\nThe usual dosage for osteoporosis is a single 5mg infusion once a year.\n\nFor Paget's disease of bone, a single 5mg infusion is typically sufficient.\n\nAdequate hydration before and after the infusion is recommended.\n\nCalcium and vitamin D supplementation may be prescribed to support bone health.\n\nFollow your doctor’s specific instructions regarding dosage and frequency.\n\nSide Effects\nCommon side effects include flu-like symptoms such as fever, chills, muscle pain, and joint pain after infusion.\n\nMay cause headache, fatigue, and nausea.\n\nCan lead to low blood calcium levels (hypocalcemia), which may require supplementation.\n\nPossible kidney function impairment, especially in patients with pre-existing conditions.\n\nRarely, osteonecrosis of the jaw (ONJ) and atypical femur fractures can occur with long-term use.\n\nAlways inform your doctor of any side effects experienced post-infusion.", "price": 3500.0, "discountamount": 1050.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "require supplementation", "recommended calcium", "usual dosage", "high risk", "jaw onj", "headache fatigue", "flulike symptoms", "healthcare professional", "action helps", "cells responsible", "binding strongly", "onceyearly infusion", "postmenopausal women", "oral treatments", "affect bones", "fractures effective", "bone tissue", "joint pain", "intravenous infusion", "bone fractures", "pagets disease", "osteoporosis pagets disease", "bone pain fractures", "preventing fractures zolmigran", "single 5mg infusion", "reducing osteoclast activity", "treating pagets disease", "atypical femur fractures", "work zolmigran works", "bone complications directions", "increased bone mass", "bone resorption leading", "bone surface specifically", "inhibiting bone resorption", "powerful intravenous medication", "kidney function impairment", "doctors specific instructions", "spinal cord compression", "prevent bonerelated complications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2110, "imageuri": "https://productimages.withfloats.com/actual/6822f6b37108c6234142be46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6822f6b37108c6234142be46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-13T07:37:22.447Z", "updatedon": "2025-05-13T07:38:19.017Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/zolmigran/2110", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "zoledronic acid injection", "category": "ORTHOLOGYRANG", "tags": [ "Zoledronic acid Injection cost", "Zoledronic acid Injection dose", "Zoledronic acid Injection price", "Zoledronic acid infusion protocol", "Zoledronic Acid Injection price in India", "Zoledronic acid injection uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a4a65aea4ed7f1f8cd234b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Methotrexate (15mg)", "description": "METROTREX 15 contains Methotrexate 15mg, a potent medication used in the treatment of autoimmune diseases and certain types of cancer. As an antifolate drug, it inhibits cell division, making it effective for managing conditions like rheumatoid arthritis, psoriasis, and leukemia.\n\n \nKey Benefits of METROTREX 15:\n \n\nMETROTREX 15 provides several therapeutic benefits, including:\n\nTreatment of Rheumatoid Arthritis: Helps reduce joint inflammation and pain by suppressing immune responses.\n\nManagement of Psoriasis: Slows down excessive skin cell production, alleviating symptoms of psoriasis.\n\nCancer Therapy: Used in chemotherapy for conditions like leukemia, breast cancer, and lymphoma by inhibiting cancer cell growth.\n\nTreatment of Crohn’s Disease: Helps in managing severe cases of inflammatory bowel disease.\n\n \nHow Does METROTREX 15 Work?\n \n\nMethotrexate 15mg works by inhibiting dihydrofolate reductase (DHFR), an enzyme essential for DNA synthesis and cell division. By blocking this enzyme, METROTREX 15 prevents the rapid multiplication of abnormal cells, making it effective in autoimmune diseases and cancer treatment.\n\n \nDirections for Use of METROTREX 15:\n \n\nTo ensure the safe and effective use of METROTREX 15, follow these guidelines:\n\nTake METROTREX 15 exactly as prescribed by your doctor.\n\nIt is usually taken once a week for autoimmune conditions and as per the oncologist’s recommendation for cancer therapy.\n\nSwallow the tablet whole with water, preferably after meals to reduce stomach irritation.\n\nRegular monitoring of blood tests is necessary to assess the drug’s effects.\n\n \nSide Effects of METROTREX 15:\n \n\nWhile METROTREX 15 is effective, it may cause some side effects, including:\n\nCommon Side Effects:\n\nNausea and vomiting\n\nFatigue\n\nMouth ulcers\n\nHair loss\n\nDizziness\n\nSerious Side Effects:\n\nLiver toxicity\n\nKidney dysfunction\n\nSuppressed bone marrow function leading to low blood cell counts\n\nIncreased risk of infections\n\nLung inflammation\n\nSeek immediate medical attention if you experience severe side effects.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "metrotrex 15", "metrotrex 15 follow", "autoimmune conditions", "medical attention", "side effects", "blood tests", "water preferably", "oncologists recommendation", "rapid multiplication", "cell division", "dna synthesis", "enzyme essential", "antifolate drug", "autoimmune diseases", "potent medication", "methotrexate 15mg", "methotrexate 15mgmetrotrex 15", "managing conditions", "therapeutic benefits", "psoriasis slows", "cancer treatment directions", "psoriasis cancer therapy", "managing severe cases", "leukemia key benefits", "cancer therapy swallow", "leukemia breast cancer", "rheumatoid arthritis psoriasis", "abnormal cells making", "inflammatory bowel disease", "crohns disease helps" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2051, "imageuri": "https://productimages.withfloats.com/actual/67a4a66d145c10370e023f04.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a4a66d145c10370e023f04.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-06T12:08:58.343Z", "updatedon": "2025-02-06T12:08:58.343Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/methotrexate-15mg-/2051", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METROTREX 15 ", "category": "", "tags": [ "Methotrexate 15 mg uses", "Methotrexate 15 mg Tablet price", "Methotrexate 15 mg Uses in Hindi", "Folitrax 15 mg tablet price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "672b543a2776dcaeeefae958", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Megestrol Acetate 40 mg", "description": "MAGRAL 40 is a specialized formulation containing Megestrol Acetate (40 mg), a synthetic progestin commonly used to help manage symptoms associated with certain medical conditions, including appetite loss and specific types of cancer. Megestrol Acetate is known for its appetite-stimulating properties, making MAGRAL 40 beneficial for patients experiencing weight loss due to chronic illness. This medication works by influencing certain hormones and pathways in the body to provide therapeutic effects that improve quality of life.\n\n \nKey Benefits:\n \n\nAppetite Stimulation: One of the primary benefits of MAGRAL 40 is its ability to increase appetite, helping patients regain lost weight and improve nutritional intake.\nManagement of Cancer Symptoms: Megestrol Acetate can help alleviate certain symptoms in hormone-responsive cancers, offering supportive care for patients managing breast or endometrial cancer.\nSupport in Chronic Illness: For patients experiencing cachexia or wasting associated with illnesses such as AIDS, MAGRAL 40 can provide relief by promoting weight gain and improving energy levels.\nHormone Regulation: As a progestin, Megestrol Acetate also influences hormone levels in the body, which can help in managing symptoms in specific medical conditions.\n \nHow Does It Work?\n \n\nMAGRAL 40 works primarily by mimicking the effects of the natural hormone progesterone. Megestrol Acetate interacts with certain hormone receptors in the body, affecting the hypothalamus and other regulatory systems to stimulate appetite and weight gain. This action is particularly beneficial in patients experiencing involuntary weight loss. Additionally, by affecting hormone levels, MAGRAL 40 helps slow the growth of hormone-sensitive cancers, such as breast and endometrial cancers, providing relief from symptoms and aiding in disease management.\n\n \nDirections for Use:\n \n\nRecommended Dosage: Take MAGRAL 40 exactly as prescribed by your healthcare provider. Dosage varies based on individual needs and medical condition.\nAdministration: Swallow the tablet with water. It can be taken with or without food, though consistency is recommended for optimal absorption.\nTiming: Follow your healthcare provider’s instructions on frequency and duration. Typically, it is taken once daily or as advised.\nMissed Dose: If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose and resume your regular schedule. Avoid doubling up on doses.\nStorage: Store MAGRAL 40 in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.\n \nSide Effects:\n \n\nWhile MAGRAL 40 is generally well-tolerated, some users may experience side effects, including:\n\nWeight Gain: As an appetite stimulant, it is common to experience an increase in body weight.\nNausea and Vomiting: Mild gastrointestinal discomfort may occur, especially at the beginning of treatment.\nMood Changes: Some patients may experience mild mood swings or changes in mental alertness.\nFatigue: Fatigue or tiredness may be noted, especially with long-term use.\nHormonal Side Effects: In rare cases, changes in menstrual cycles or other hormone-related effects may occur.", "price": 300.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "40 mg", "next dose", "rare cases", "body weight", "weight gain", "Mood Changes", "Key Benefits", "long-term use", "appetite loss", "energy levels", "hormone levels", "specific types", "Cancer Symptoms", "direct sunlight", "supportive care", "chronic illness", "cool, dry place", "menstrual cycles", "mental alertness", "regular schedule", "individual needs", "primary benefits", "mild mood swings", "Megestrol Acetate", "hormone receptors", "Recommended Dosage", "disease management", "appetite stimulant", "optimal absorption", "nutritional intake", "Hormone Regulation", "synthetic progestin", "healthcare provider", "endometrial cancers", "therapeutic effects", "Appetite Stimulation", "Hormonal Side Effects", "specialized formulation", "involuntary weight loss", "other regulatory systems", "hormone-sensitive cancers", "hormone-responsive cancers", "specific medical conditions", "natural hormone progesterone", "other hormone-related effects", "appetite-stimulating properties", "Mild gastrointestinal discomfort" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2024, "imageuri": "https://productimages.withfloats.com/actual/672b547c9e5dd930f66a2c88.png", "tileimageuri": "https://productimages.withfloats.com/tile/672b547c9e5dd930f66a2c88.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-11-06T11:34:18.872Z", "updatedon": "2024-11-06T11:34:18.872Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/megestrol-acetate-40-mg/2024", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MAGRAL 40 ", "category": "gynaecology", "tags": [ "What is megestrol 40 mg used for", "", "Megestrol acetate 40 mg side effects", "Megestrol acetate side effects", "Megestrol Acetate 40 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d1f7b6be1220f389cf9a3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "THYRORISE 200 ", "description": "THYRORISE 200 \nThyroxine Sodium (200mcg)\nOverview\nTHYRORISE 200 is a pharmaceutical formulation containing Thyroxine Sodium, a synthetic form of the thyroid hormone thyroxine (T4), at a dosage of 200 mcg. Thyroxine is crucial for regulating metabolism, energy production, and overall endocrine health. THYRORISE 200 is prescribed for individuals with hypothyroidism, a condition where the thyroid gland does not produce enough hormones, leading to symptoms such as fatigue, weight gain, and depression.\n\nBenefits of Thyroxine Sodium\n\nRegulation of Metabolism\n\nThyroxine plays a vital role in regulating the body's metabolic rate.\nIt helps convert food into energy, supporting weight management and energy levels.\nSupport for Cardiovascular Health\n\nProper levels of thyroxine ensure the normal function of the heart.\nIt helps maintain healthy heart rate and blood pressure, reducing the risk of cardiovascular diseases.\nEnhancement of Cognitive Function\n\nAdequate thyroxine levels are essential for brain development and function.\nIt improves cognitive abilities, memory, and concentration, preventing cognitive decline.\nMood Stabilization\n\nThyroxine helps regulate mood and emotional well-being.\nIt can alleviate symptoms of depression and anxiety associated with hypothyroidism.\nHealthy Growth and Development\n\nCrucial for normal growth and development in children.\nEnsures proper development of bones, muscles, and the nervous system.\nUsage and Dosage\nTHYRORISE 200 should be taken as prescribed by a healthcare professional. The typical starting dose for adults with hypothyroidism is individualized based on the patient's age, weight, cardiovascular status, and other health conditions. It is usually taken once daily on an empty stomach, preferably 30 minutes to an hour before breakfast to enhance absorption.\n\nIndications for Use\n\nHypothyroidism: Effective in treating primary, secondary, and tertiary hypothyroidism.\nGoiter: Helps reduce the size of an enlarged thyroid gland.\nThyroid Cancer: Used as part of the treatment regimen for certain types of thyroid cancer.\nThyroid Hormone Replacement: For patients with thyroidectomy or radioactive iodine therapy.\nSide Effects\nWhile THYRORISE 200 is generally well-tolerated, some individuals may experience side effects, especially if the dosage is not properly adjusted. Possible side effects include:\n\nCardiovascular Issues: Palpitations, increased heart rate, and hypertension.\nNervous System Effects: Nervousness, irritability, and tremors.\nGastrointestinal Symptoms: Diarrhea, weight loss, and increased appetite.\nOthers: Hair loss, muscle weakness, and menstrual irregularities.\nPrecautions and Contraindications\n\nCardiovascular Conditions: Patients with heart disease or hypertension should use THYRORISE 200 with caution and under close medical supervision.\nDiabetes: Thyroxine can affect blood sugar levels; diabetic patients may need adjustments to their diabetes medication.\nPregnancy and Lactation: Adequate thyroxine levels are crucial during pregnancy; however, dosage adjustments may be necessary. Consult a healthcare provider.\nDrug Interactions: Thyroxine can interact with various medications, including anticoagulants, insulin, and certain antidepressants. Inform your healthcare provider of all medications you are taking.\nConclusion\nTHYRORISE 200 provides an effective solution for individuals with hypothyroidism and related conditions. By supplementing the body's thyroxine levels, it helps restore normal metabolic function, enhances cardiovascular and cognitive health, and improves overall well-being. Under the guidance of a healthcare professional, THYRORISE 200 can significantly improve the quality of life for those suffering from thyroid hormone deficiencies.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Hair loss", "vital role", "weight loss", "weight gain", "heart disease", "empty stomach", "energy levels", "normal growth", "Proper levels", "synthetic form", "Thyroid Cancer", "Healthy Growth", "blood pressure", "metabolic rate", "muscle weakness", "enough hormones", "normal function", "Thyroxine Sodium", "cognitive health", "diabetic patients", "brain development", "energy production", "weight management", "Drug Interactions", "treatment regimen", "cognitive decline", "dosage adjustments", "proper development", "Mood Stabilization", "effective solution", "Cognitive Function", "related conditions", "overall well-being", "healthy heart rate", "blood sugar levels", "various medications", "diabetes medication", "healthcare provider", "cognitive abilities", "emotional well-being", "Cardiovascular Issues", "cardiovascular status", "Cardiovascular Health", "Possible side effects", "typical starting dose", "Nervous System Effects", "enlarged thyroid gland", "tertiary hypothyroidism", "cardiovascular diseases", "healthcare professional", "other health conditions", "menstrual irregularities", "overall endocrine health", "Gastrointestinal Symptoms", "Cardiovascular Conditions", "normal metabolic function", "Adequate thyroxine levels", "close medical supervision", "pharmaceutical formulation", "radioactive iodine therapy", "Thyroid Hormone Replacement", "thyroid hormone deficiencies" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1920, "imageuri": "https://productimages.withfloats.com/actual/668d1fa94944b8c562115315.png", "tileimageuri": "https://productimages.withfloats.com/tile/668d1fa94944b8c562115315.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:31:07.271Z", "updatedon": "2024-07-09T11:31:07.271Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/thyrorise-200-/1920", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THYRORISE 200 ", "category": "DIABETICSRANGE", "tags": [ "Thyroxine 200 mg side effects", "is 200 mcg of levothyroxine, a high dose", "Thyroxine 200 mg uses", "Thyrox 200 mg", "Thyronorm 200 mcg uses", "Thyroxine Sodium Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
colorectal cancer?

Still searching for
colorectal cancer?

Chat with us